サインイン

Vincenza Conteduca

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS

BIOGRAPHY

Vincenza Conteduca has not added Biography.

If you are Vincenza Conteduca and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abiraterone.

Oncotarget Dec, 2014 | Pubmed ID: 25504434

Circulating AR copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer.

Oncotarget Jun, 2016 | Pubmed ID: 27191887

Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib.

Oncotarget 08, 2016 | Pubmed ID: 27409344

Cell-free DNA as a diagnostic marker for cancer: current insights.

OncoTargets and therapy , 2016 | Pubmed ID: 27822059

Circulating androgen receptor combined with 18F-fluorocholine PET/CT metabolic activity and outcome to androgen receptor signalling-directed therapies in castration-resistant prostate cancer.

Scientific reports Nov, 2017 | Pubmed ID: 29138500

INSTITUTIONS

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS

JOVE ARTICLES

Serum and Plasma Copy Number Detection Using Real-time PCR

Samanta Salvi¹,

Vincenza Conteduca¹,

Filippo Martignano¹,

Giorgia Gurioli¹,

Daniele Calistri¹,

Valentina Casadio¹

¹, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS

Cancer Research

個人情報保護方針

利用規約

一般データ保護規則

お問い合わせ

図書館への推薦

JoVE ニュースレター

研究

JoVE Journal
メソッドコレクション
JoVE Encyclopedia of Experiments
アーカイブ

教育

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教員向けリソースセンター
教員用サイト

著者

概要
出版プロセス
編集委員会
スコープと指針
査読
よくある質問
お申し込み

図書館員

概要
お客様の声
定期購読
アクセス
リソース
図書館諮問委員会
よくある質問

JoVEについて

概要
経営陣
ブログ
JoVE Help Center